
ALK is starting its clinical trial of a tablet vaccine against peanut allergies, it reveals in a press release.
The company’s new tablet vaccine will be tested in a clinical phase I study. The trial will be called Alliance and take place in North America.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app